(Reuters) -Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico by 2026, Chief Financial Officer Lucas Montarce said on Monday at the Leerink Partners Global Healthcare Conference.
(Reporting by Sriparna Roy and Christy Santhosh in Bengaluru; Editing by Leroy Leo)
Disclaimer: This report is auto generated from the Reuters news service. ThePrint holds no responsibility for its content.